Human Vaccines & Immunotherapeutics
Volume 18, 2022 - Issue 1
Pneumococcal – Letter
Reply letter to “response to article by Johnna Perdrizet et al.” by Gomez and colleagues
Johnna Perdrizeta Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USACorrespondence[email protected]
https://orcid.org/0000-0002-4260-7607View further author information
https://orcid.org/0000-0002-4260-7607View further author information, , , Rodrigo Fernandes Alexandreb Health Economics and Outcomes Research, Pfizer Inc, Sao Paulo, Brazilhttps://orcid.org/0000-0002-1010-276XView further author information
https://orcid.org/0000-0002-1010-276XView further author information, , & Matt Wassermana Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USAhttps://orcid.org/0000-0003-3300-2742View further author information
https://orcid.org/0000-0003-3300-2742View further author information show all